Cornell University’s James Antaki had a $6.7 million Department of Defense grant for his life-saving PediaFlow device, designed to improve blood flow in infants with heart defects, revoked without explanation. This follows three decades of research and prior successful grant applications, jeopardizing the project’s completion and potentially impacting hundreds of lives. The sudden cancellation is attributed to a broader trend of funding cuts under the current administration, impacting numerous research projects across various fields. Without restored funding, Antaki’s team faces layoffs and project termination, hindering progress towards a crucial medical device for infants with life-threatening heart conditions.
Read More
A federal judge issued a temporary injunction halting the National Institutes of Health’s (NIH) plan to drastically cut medical research grant funding, following a lawsuit from 22 states. This action, pending further legal arguments, temporarily prevents the implementation of a 15% cap on indirect costs—a significant reduction from the current average of 27-28%— impacting research institutions in the plaintiff states. The NIH claims the cuts, opposed by numerous research institutions and organizations, would save over $4 billion annually. The Senate’s upcoming confirmation vote on President Trump’s nominee to head the NIH may affect the policy’s future.
Read More
Twenty-two state attorneys general are challenging a Trump administration policy that slashes National Institutes of Health funding for indirect research costs to 15%, impacting crucial medical research. This lawsuit, filed in Massachusetts, argues the cuts will severely harm research institutions and impede medical innovation. The policy has drawn bipartisan criticism, with Senator Susan Collins citing the arbitrary nature of the cuts and their potential to halt vital research. Despite legislative prohibitions against the funding modification, the administration is moving forward with the policy, prompting the legal challenge.
Read More
The Trump administration’s National Institutes of Health (NIH) implemented a $4 billion annual reduction in indirect medical research funding, limiting associated costs to 15% of awarded grants. This decision, justified as reallocating funds towards direct research, is projected to significantly impact universities and research institutions. Critics, including Democrats and research organizations, warn of potentially catastrophic consequences for vital medical research and innovation, with potential harm to patients. Supporters, conversely, praise the move as efficient government spending.
Read More
John Q. Hosedrinker